論文

• I. Ajioka, R. Nishio, T. Akaike, M. Sasaki, J. Enami, *Y. Watanabe. Establishment of heterotropic liver tissue mass with direct link to the host liver following implantation of hepatocytes transfected with vascular endothelial growth factor gene in mice., Tissue Engineering, Vol. 7, pp. 335-344, 2001.
• Y. Watanabe, K. Hirakawa, T. Haruyama, T. Akaike. Direct production of an activated matrix metalloproteinase-9 (gelatinase B) from mammalian cells. , FEBS Lett., Vol. 502, pp. 63-67, 2001.
• I. Ajioka, T. Akaike, Y. Watanabe. Ethanolamine regulates the transition from G2 to M phase of primary cultured hepatocytes by inducing cyclin B expression via cytoskeletal rearrangement., Mol. Biol. Cell, Vol. 11, pp. 342a, 2000.
• I. Shibuya, T. Akaike, Y. Watanabe. Suppression of Fas-mediated hepatic apoptosis by caspase inhibitor-encapsulated nanoparticles bearing poly-(N-p-vinylbenzyl-O-b-D-galactopyranosyl-[1-4]-D-gluconamide)., Biotech. Lett., Vol. 22, pp. 1855-1859, 2000.
• T. Haruyama, I. Ajioka, T. Akaike, Y. Watanabe. Regulation and significance of hepatocyte-derived matrix metalloproteinases (MMP) in liver remodeling., Biochem. Biophys. Res. Commun., Vol. 273, pp. 681-686, 2000.
• I. Shibuya, T. Akaike, Y. Watanabe. Design of temporally and spatially controlled drug delivery system for the treatment of liver diseases in mice., Hepatology, Vol. 32, pp. 1299-1307, 2000.
• Y. Watanabe, X. Liu, I. Shibuya, T. Akaike. Functional evaluation of poly-N-vinylbenzyl-D-lactonamide (PVLA) as a liver specific carrier., J. Biomaterials Sci., Polymer Ed., Vol. 11, pp. 833-848, 2000.
• I. Ajioka, T, Akaiek, Y. Watanabe. Expression of vascular endothelial growih factor (VEGF) promotes colonization, vascularization and growth of transplanted hepatic tissues in mice, Hepatology, Vol. 29, pp. 396-402, 1999.
• YOSHIFUMI WATANABE. Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice., Genes to Cells, Vol. 4, pp. 563-572, 1999.
• T. Haruyama, A. Kano, T. Akaike, Y. Watanabe. IRF-1 is an essential mediator in IFN-γ-induced cell cycle arrest and apoptosis of primary cultured hepatocyies, Biochem. Biophys. Res. Commun., Vol. 257, pp. 672-677, 1999.
• 渡辺恵史. 細胞死誘導酵素阻害剤による肝炎治療薬の開発, 医科学応用研究財団報告, Vol. 17, pp. 235-239, 1998.
• 渡邊惠史. バイオ人工肝臓-細胞生物学から組織工学へのチャレンジー, SUT Bulletin, Vol. 2, pp. 16, 1998.
• 渡邊惠史. 遺伝子導入による生体内自己組織化型人工肝臓, 人工臓器, pp. 27, 1998.
• YOSHIFUMI WATANABE. TNFα bifunctionally induces proliferation in primary hepatocytes : Role of cell anchorage and spreading, J. Immunol., Vol. 159, pp. 4840, 1997.
• YOSHIFUMI WATANABE. Identification and characterization of murine Caspase family genes expressed in IFN-γ-induced hepatic apoptosis, Hepatology, Vol. 26, pp. 265A, 1997.
• YOSHIFUMI WATANABE. Analysis of IFN-γ-induced cell cycle arrest and cell death in hepatocytes., J. Biochem, Vol. 121, pp. 677-683, 1997.
• YOSHIFUMI WATANABE. VPF/VEGF delays and induces escape from senescence in human dermal microvascular endothelial cells., Oncogene, Vol. 14, pp. 2025-2032, 1997.
• YOSHIFUMI WATANABE. VPF/VEGF inhibits anchorage-disroption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation., Exp. cell Res., Vol. 233, pp. 340-349, 1997.
• YOSHIFUMI WATANABE. Concanavalin A induces perforin-mediated but not Fas-mediated cytotoxicity in liver injury., Hepatology, Vol. 24, pp. 702-710, 1996.
• YOSHIFUMI WATANABE. Tumor necrosis factor α and IL-Iβ but not IFN-α induces VCAM-1 expression on primary cultured murine hepatocytes., Biochem. Biophys. Res. Commun., Vol. 209, pp. 335-342, 1995.
• YOSHIFUMI WATANABE. Direct evidence of macrophage differentiation from bone marrow cells in the liver : the origin of Kupffer cells., J. Biochem, Vol. 118, pp. 1175-1183, 1995.
• YOSHIFUMI WATANABE. Primary cultured murine hepatocytes but not hepatoma cells regulate the cell number through density-dependent cell death., Cell Death & Differentiation, Vol. 2, pp. 127-134, 1995.
• YOSHIFUMI WATANABE. Inflammatory cytokines upregulate the ICAM-1 expression on primary cultured mouse dhepatocytes and T cell adhesion., Hepatology, No. 19, pp. 426-431, 1994.
• YOSHIFUMI WATANABE. Activation signal induces the expression of B cell specific CD45R (6B2) epitope on T cells., Scand. J. Immunol., Vol. 39, pp. 419-425, 1994.
• YOSHIFUMI WATANABE. Highly efficient transfection into primary cultured mouse hepatocytes by use of cation-liposomes : An application for immunization., J. Biochemistry, Vol. 116, pp. 1220-1226, 1994.
• YOSHIFUMI WATANABE. Determination of mouse major asialoglycoprotein receptor cDNA sequence., Biochim. Biophys. Acta., No. 1172, pp. 220-222, 1993.
• YOSHIFUMI WATANABE. Enhancement by inflammatory cytokines of ICAM-1 expression on hepatocytes and T cell adhesion., Lymphokine and Cytokine Res., No. 12, pp. 373, 1993.
• YOSHIFUMI WATANABE. Synthesis of a new polymer containing a blood-group antigenic oligosaccharide chain., Macromolecules., No. 26, pp. 1483-1486, 1993.
• YOSHIFUMI WATANABE. Enhancement by IL-Iβ and IFN-α of platelet activation : adhesion to leukocytes via GMP-140 /PADGEM protein (CD62)., Biochem. Biophys. Res. Commune, pp. 179, 1991.
• YOSHIFUMI WATANABE. Regulation of MHC class II antigen expression : Opposing effect of TNF-α on MHC calss II expression in cell differentiation stages., J. Immunol., pp. 146, 1991.
• YOSHIFUMI WATANABE. Effect of systeine on borine serum blbumin(BSA) denaturation induced by solar ultraviolet light (VVA, UVB), Chem. Pharm. Bull, pp. 39, 1991.
• YOSHIFUMI WATANABE. Control of expression of a class II MHC (HLA-DR) in various human cell types., Scand. J. Immund., pp. 32, 1990.
• YOSHIFUMI WATANABE. Effect of ricin or ricin A-dhain containing liposomes bcaring anti-CEA antibody on human CEA producing tumor cell lines, Chem. Pham. Bull., pp. 35, 1987.
• YOSHIFUMI WATANABE. Preparation and antitumor effect of macrophage activating factor (MAF) entrapped in liposomes vearing monoclonal anti-human melanoma (A375) antibody., J. Biol. Res. Modi., pp. 6, 1987.
• YOSHIFUMI WATANABE. Effect of a monoclonal anti-CEA antbody-ricin-A-chain comjugate on human CEA-produing cells, J. Pharm. Dyn., pp. 7, 1984.
• YOSHIFUMI WATANABE. The carbohydrate moiety of human platelet glycocalicin The structure of the major Ser/Thr-linked sugar Chain., J. Biol. Chem., pp. 258, 1983.

著書

• 渡辺恵史, 渋谷功, 赤池敏宏. DDSによる肝疾患治療, ドラッグデリバリーシステム, ドラッグデリバリーシステム, Vol. 16, pp. 39-49, 2001.
• 渡辺恵史, 味岡逸樹, 赤池敏宏. 遺伝子操作と新素材を用いた臓器工学, 蛋白質・核酸・酵素, 蛋白質・核酸・酵素, Vol. 45, pp. 1376-1382, 2000.

学位論文

• Monoclonal抗体を用いたdrug delivery systemの研究,  本文,  Doctor of Pharmaceutical Science,  The University of Tokyo,  1986/--/--, 
• ,  Master of Pharmaceutical Science, 

[ BibTeX 形式で保存 ]    [ 論文・著書をCSV形式で保存 ]    [ 特許をCSV形式で保存 ]